Septerna, Inc.

SEPN Nasdaq Healthcare · Pharmaceutical Preparations South San Francisco, CA www.septerna.com/
$49.36
Mkt Cap 2.30B

Biotechnology company developing small-molecule drugs that target G protein-coupled receptors; no approved products yet.

septerna.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$98.9M
1644.5% CAGR
FCF TTM
$105.1M
106.3% margin
P/FCF
21.9x
—
Running full 6-factor analysis…